AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2004
Apr 5, 2004
34519_dirs_2004-04-05_0a3b04b3-f338-4203-a823-02f351af48fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-03-26
Reporting Person: CRABB JOSEPH H (Director, Vice President & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-03-26 | Common Stock, par value $0.10 per share | M | 10000 | $2.0625 | Acquired | 66000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-03-26 | Incentive stock options (right to buy) | $2.0625 | M | 10000 | Disposed | 2004-06-03 | common stock (10000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23